HomeCompareDTXMF vs PLD

DTXMF vs PLD: Dividend Comparison 2026

DTXMF yields 2099.96% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTXMF wins by $15665483167.89M in total portfolio value
10 years
DTXMF
DTXMF
● Live price
2099.96%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15665483173.80M
Annual income
$14,323,699,878,768,094.00
Full DTXMF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — DTXMF vs PLD

📍 DTXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTXMFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTXMF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTXMF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTXMF
Annual income on $10K today (after 15% tax)
$178,496.43/yr
After 10yr DRIP, annual income (after tax)
$12,175,144,896,952,880.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, DTXMF beats the other by $12,175,144,892,914,764.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTXMF + PLD for your $10,000?

DTXMF: 50%PLD: 50%
100% PLD50/50100% DTXMF
Portfolio after 10yr
$7832741589.85M
Annual income
$7,161,849,941,759,410.00/yr
Blended yield
91.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

DTXMF
No analyst data
Altman Z
8.7
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTXMF buys
0
PLD buys
0
No recent congressional trades found for DTXMF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTXMFPLD
Forward yield2099.96%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$15665483173.80M$5.91M
Annual income after 10y$14,323,699,878,768,094.00$4,750,725.19
Total dividends collected$15570599104.15M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DTXMF vs PLD ($10,000, DRIP)

YearDTXMF PortfolioDTXMF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$220,696$209,995.80$11,241$540.96+$209.5KDTXMF
2$4,567,471$4,331,326.27$13,019$991.13+$4.55MDTXMF
3$88,663,041$83,775,847.71$15,801$1,870.97+$88.65MDTXMF
4$1,614,723,560$1,519,854,105.24$20,609$3,701.21+$1614.70MDTXMF
5$27,596,399,156$25,868,644,947.25$29,919$7,867.97+$27596.37MDTXMF
6$442,712,758,641$413,184,611,544.43$50,631$18,617.74+$442712.71MDTXMF
7$6,668,541,041,184$6,194,838,389,437.68$105,528$51,352.20+$6668540.94MDTXMF
8$94,343,071,214,447$87,207,732,300,379.95$287,364$174,449.42+$94343070.93MDTXMF
9$1,254,003,079,467,744$1,153,055,993,268,286.20$1,081,760$774,280.77+$1254003078.39MDTXMF
10$15,665,483,173,798,580$14,323,699,878,768,094.00$5,908,209$4,750,725.19+$15665483167.89MDTXMF

DTXMF vs PLD: Complete Analysis 2026

DTXMFStock

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

Full DTXMF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this DTXMF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTXMF vs SCHDDTXMF vs JEPIDTXMF vs ODTXMF vs KODTXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.